Variables | Cases N (%) | Controls N (%) | OR(95%CI) | OR(95%CI)a |
---|---|---|---|---|
Cpn | ||||
 Cpn IgG | ||||
  -(< 1:64) | 121 (26.9) | 185 (36.1) | 1.00 | 1.00 |
   + (≥1:64) | 328 (73.1) | 327 (63.9) | 1.53 (1.16–2.02) | 1.42 (1.02–1.96) |
 Cpn IgA | ||||
  -(< 1:32) | 265 (59.0) | 376 (73.4) | 1.00 | 1.00 |
   + (≥1:32) | 184 (41.0) | 136 (26.6) | 1.92 (1.46–2.52) | 1.73 (1.25–2.38) |
 Cpn IgG or IgA | ||||
  both- | 105 (23.4) | 161 (31.4) | 1.00 | 1.00 |
  single+ | 176 (39.2) | 239 (46.7) | 1.13 (0.83–1.55) | 1.07 (0.74–1.54) |
  both+ | 168 (37.4) | 112 (21.9) | 2.30 (1.63–3.24) | 2.00 (1.34–3.00) |
Ctr | ||||
 Ctr IgG | ||||
  -(< 1:64) | 376 (83.7) | 447 (87.3) | 1.00 | 1.00 |
   + (≥1:64) | 73 (16.3) | 65 (12.7) | 1.34 (0.93–1.92) | 1.04 (0.69–1.58) |
  Ctr IgA | ||||
  -(< 1:32) | 443 (98.7) | 509 (99.4) | 1.00 | 1.00 |
   + (≥1:32) | 6 (1.3) | 3 (0.6) | 2.30 (0.57–9.24) | 1.32 (0.30–5.86) |
 Ctr IgG or IgA | ||||
  both- | 373 (83.1) | 446 (87.1) | 1.00 | 1.00 |
  single+ | 73 (16.3) | 64 (12.5) | 1.36 (0.95–1.96) | 1.06 (0.69–1.61) |
  both+ | 3 (0.6) | 2 (0.4) | 1.79 (0.30–10.79) | 1.12 (0.17–7.58) |
Cps | ||||
  Cps IgG | ||||
  -(< 1:64) | 406 (90.4) | 481 (93.9) | 1.00 | 1.00 |
   + (≥1:64) | 43 (9.6) | 31 (6.1) | 1.64 (1.02–2.66) | 1.28 (0.73–2.22) |
 Cps IgA | ||||
  -(< 1:32) | 444 (98.9) | 508 (99.2) | 1.00 | 1.00 |
   + (≥1:32) | 5 (1.1) | 4 (0.8) | 1.43 (0.38–5.36) | 1.82 (0.41–8.10) |
 Cps IgG or IgA | ||||
  both- | 404 (90.0) | 478 (93.4) | 1.00 | 1.00 |
  single+ | 42 (9.4) | 33 (6.4) | 1.51 (0.94–2.42) | 1.18 (0.68–2.05) |
  both+ | 3 (0.6) | 1 (0.2) | 3.55 (0.37–34.26) | 4.02 (0.36–45.59) |